Luca Pani, Medical Doctor, specialized in Psychiatry is an Expert in Pharmacology and Molecular Biology, and a Fellow of the National Research Council of Italy who has served as Director General of the Italian Medicines Agency (AIFA) from 2011 to 2016, with the CEO role of both Regulator and Negotiator / Payer. Prof. Pani is currently associated with the Faculty and the Department of Psychiatry and Behavioural Sciences of the University of Miami School of Medicine.
Luca Pani’s professional trajectory has touched several areas of expertise from preclinical study to clinical activity as well as R&D of CNS drugs, along with his commitment to teaching on experimental and clinical cases. He has attended national and international regulatory activities for the European Union. During the past decade he has prepared, evaluated and coordinated vast research projects with strategic planning and partnerships collaborating with national and international research groups also by participating in international bodies and advisory committees worldwide both at the scientific and regulatory / HTA level.
Italian Member of the Committee for Human Medicine Products (CHMP); Member of the Scientific Advice Working Party (SAWP); participant of the Working Party on Central Nervous System (WPCNS); he serves as Chair of the European Union Management Board Telematic Committee (EUMBTC) and Chair of the EU Network Pharmacovigilance Oversight Group for the European Medicines Agency (EMA) in London (UK).
Luca Pani is the author of over one hundred and fifty scientific publications, editor and author of several volumes and also writer of successful leisure literature. He has attended more than 1000 conferences, seminars and national and international roundtables as an invited speaker.